NU Skin Enterprises, Inc.: Form 10-K for the period ended Dec 31, 2015
Filed with the SEC on Feb 18, 2016 and accepted by EDGAR at Feb 18, 2016, 07:37 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2015-01-01 to 2015-12-31 | $489.5m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2015-10-01 to 2015-12-31 | $450.8m | us-gaap:GrossProfit |
| Gross profit | 12 months2015-01-01 to 2015-12-31 | $1.76bn | us-gaap:GrossProfit |
| Research and development | 12 months2015-01-01 to 2015-12-31 | $20.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2015-10-01 to 2015-12-31 | $61.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2015-01-01 to 2015-12-31 | $244.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2015-01-01 to 2015-12-31 | $7.9m | us-gaap:InterestExpense |
| Income tax | 12 months2015-01-01 to 2015-12-31 | $78.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-10-01 to 2015-12-31 | $35.8m | us-gaap:NetIncomeLoss |
| Net income | 12 months2015-01-01 to 2015-12-31 | $133.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-10-01 to 2015-12-31 | $0.62 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2015-01-01 to 2015-12-31 | $2.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-10-01 to 2015-12-31 | $0.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2015-01-01 to 2015-12-31 | $2.29 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2015-01-01 to 2015-12-31 | 59,057,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 12 months2015-01-01 to 2015-12-31 | $56.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2015-01-01 to 2015-12-31 | $81.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2015-01-01 to 2015-12-31 | $164.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-12-31 | $289.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-12-31 | $706.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-12-31 | $1.51bn | us-gaap:Assets |
| Current liabilities | At period end2015-12-31 | $407.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-12-31 | $680.2m | us-gaap:Liabilities |
| Long-term debt | At period end2015-12-31 | $181.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-12-31 | $67.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2015-12-31 | $825.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001021561-16-000100. Last ingested by Listed: Nov 5, 2026, 18:30 ET. Listed shows no prices and gives no investment advice.